Vitaspring Biomedical (VSBC) Liabilities and Shareholders Equity (2017 - 2026)
Vitaspring Biomedical's Liabilities and Shareholders Equity was $14,822 in fiscal Q2 2027 (quarter ended Jul 31, 2026), down 12.9% from $17,020 a year earlier but up 29.7% from the prior quarter.
Powered by 
Analysis
Vitaspring Biomedical (VSBC) Liabilities and Shareholders Equity (2017 - 2026) Analysis & Trends
At the end of FY2026 (ended Jan 31, 2026), Liabilities and Shareholders Equity at Vitaspring Biomedical came in at $14,676, up 2.1% from FY2025.
- Liabilities and Shareholders Equity shows a five-year compound annual growth rate of -40.0% (FY2021 to FY2026).
- In earlier fiscal years, Liabilities and Shareholders Equity was $14,378 in FY2025 (-89.5%), $137,342 in FY2024 (-82.1%), $765,948 in FY2023 (-78.7%) and $3.6 million in FY2022.
- Quarterly Liabilities and Shareholders Equity has moved between $11,432 (fiscal Q1 2027) and $3.6 million (fiscal Q4 2022) over five years.
- Compared with a year earlier, Liabilities and Shareholders Equity was higher in 1 of the last eight quarters, with an average decline of 52.5%.
- The best year-over-year quarter for Liabilities and Shareholders Equity over five years was fiscal Q1 2023 (growth of 485.6%); the worst was fiscal Q1 2026 (a decline of 90.9%).
- Per Business Quant data, VSBC's Liabilities and Shareholders Equity in the three fiscal quarters before Q2 2027 was $11,432 (Q1 2027), $14,676 (Q4 2026) and $16,465 (Q3 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Vitaspring Biomedical | 2.07 Mn | 2.04 Mn | - | 14,822.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 14,822.00 |
| Apr 30, 2026 | 11,432.00 |
| Jan 31, 2026 | 14,676.00 |
| Oct 31, 2025 | 16,465.00 |
| Jul 31, 2025 | 17,020.00 |
| Apr 30, 2025 | 11,912.00 |
| Jan 31, 2025 | 14,378.00 |
| Oct 31, 2024 | 58,382.00 |
| Jul 31, 2024 | 64,334.00 |
| Apr 30, 2024 | 131,288.00 |
| Jan 31, 2024 | 137,342.00 |
| Oct 31, 2023 | 277,349.00 |
| Jul 31, 2023 | 404,906.00 |
| Apr 30, 2023 | 548,544.00 |
| Jan 31, 2023 | 765,948.00 |
| Oct 31, 2022 | 2.44 Mn |
| Jul 31, 2022 | 2.58 Mn |
| Apr 30, 2022 | 2.70 Mn |
| Jan 31, 2022 | 3.60 Mn |
| Oct 31, 2021 | 1.14 Mn |
API Access
Vitaspring Biomedical Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VSBC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "VSBC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=VSBC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();